Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria (PRIORITY)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Steno Diabetes Center
Mosaiques Diagnostics GmbH
University Medical Center Groningen
University of Glasgow
Istituto Di Ricerche Farmacologiche Mario Negri
Univerzita Karlova v Praze
Charite University, Berlin, Germany
Geniko Nosokomeio Athinas Ippokrateio
Institut Klinické a Experimentální Mediciny Praze
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Institut Universitaire de Recherche Clinique Montpellier
Klinikum St. Georg Leipzig
Universitaet Zürich
Cyril and Methodius University in Skopje
Hannover Clinical Trial Center
European Commission
Information provided by (Responsible Party):
Peter Rossing, Steno Diabetes Center Identifier:
First received: December 16, 2013
Last updated: January 30, 2015
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):